logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
Ceased 3
  • 1
    Tate, Duncan Saxon
    Director born in April 1968
    Individual (2 offsprings)
    Officer
    icon of calendar 2018-04-03 ~ 2021-04-29
    OF - Director → CIF 0
  • 2
    Swarbrick, Adam
    Accountant born in August 1992
    Individual (43 offsprings)
    Officer
    icon of calendar 2017-05-18 ~ 2018-02-16
    OF - Director → CIF 0
    Mr Adam Swarbrick
    Born in August 1992
    Individual (43 offsprings)
    Person with significant control
    icon of calendar 2017-05-18 ~ 2018-03-06
    PE - Ownership of shares – 75% or moreCIF 0
  • 3
    Yazdabadi, Alan Adi
    Chartered Accountant born in May 1980
    Individual (27 offsprings)
    Officer
    icon of calendar 2018-02-16 ~ 2018-05-23
    OF - Director → CIF 0
parent relation
Company in focus

SUGARCANE BIOPRODUCTS (HOLDINGS) LIMITED

Previous name
PHARMOL (HOLDINGS) LIMITED - 2018-09-11
Standard Industrial Classification
82990 - Other Business Support Service Activities N.e.c.
Brief company account
Current Assets
87,002 GBP2024-03-31
112,137 GBP2023-03-31
Creditors
Amounts falling due within one year
-7,000 GBP2024-03-31
-31,000 GBP2023-03-31
Net Current Assets/Liabilities
80,002 GBP2024-03-31
81,137 GBP2023-03-31
Total Assets Less Current Liabilities
80,002 GBP2024-03-31
81,137 GBP2023-03-31
Creditors
Amounts falling due after one year
-4,965,727 GBP2024-03-31
-4,519,759 GBP2023-03-31
Net Assets/Liabilities
-4,885,725 GBP2024-03-31
-4,438,622 GBP2023-03-31
Equity
-4,885,725 GBP2024-03-31
-4,438,622 GBP2023-03-31
Average Number of Employees
02023-04-01 ~ 2024-03-31
02022-04-01 ~ 2023-03-31

Related profiles found in government register
  • SUGARCANE BIOPRODUCTS (HOLDINGS) LIMITED
    Info
    PHARMOL (HOLDINGS) LIMITED - 2018-09-11
    Registered number 10778679
    icon of addressLevel 4 Ldn:w, 3 Noble Street, London EC2V 7EE
    PRIVATE LIMITED COMPANY incorporated on 2017-05-18 (8 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2025-05-09
    CIF 0
  • SUGARCANE BIOPRODUCTS (HOLDINGS) LIMITED
    S
    Registered number missing
    icon of address3, Noble Street, London, Greater London, England, EC2V 7EE
    Private Limited Company
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • icon of addressLevel 4 Ldn:w, 3 Noble Street, London, England
    Active Corporate (3 parents)
    Equity (Company account)
    1 GBP2024-05-31
    Person with significant control
    icon of calendar 2019-02-01 ~ now
    CIF 1 - Ownership of shares – 75% or moreOE

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.